Increases in natriuretic peptides precede heart failure hospitalization in patients with a recent coronary event and type 2 diabetes

被引：0
|
作者：
Claggett, B. [1 ]
Wolsk, E. [2 ]
Pfeffer, M. A. [1 ]
Diaz, R. [3 ]
Dickstein, K. [4 ]
Gerstein, H. C. [5 ]
Kober, L. V. [2 ]
Lawson, F. C. [6 ]
Lewis, E. F. [1 ]
Maggioni, A. P. [7 ]
Mcmurray, J. J. V. [8 ]
Probstfield, J. L. [9 ]
Riddle, M. C. [10 ]
Solomon, S. D. [1 ]
Tardif, J. C. [11 ]
机构：
[1] Brigham & Womens Hosp, Cardiol, 75 Francis St, Boston, MA 02115 USA
[2] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[3] Estudios Cardiol Latinoamer ECLA, Rosario, Santa Fe, Argentina
[4] Stavanger Univ Hosp, Stavanger, Norway
[5] McMaster Univ, Hamilton, ON, Canada
[6] Sanofi US, Bridgewater, NJ USA
[7] Italian Assoc Hosp Cardiologists, Res Ctr, Florence, Italy
[8] Univ Glasgow, Glasgow, Lanark, Scotland
[9] Univ Washington, Seattle, WA 98195 USA
[10] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[11] Montreal Heart Inst, Montreal, PQ, Canada
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
879
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [1] Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
    Wolsk, Emil
    Claggett, Brian
    Diaz, Rafael
    Dickstein, Kenneth
    Gerstein, Hertzel C.
    Kober, Lars
    Lawson, Francesca C.
    Lewis, Eldrin F.
    Maggioni, Aldo P.
    McMurray, John J. V.
    Probstfield, Jeffrey L.
    Riddle, Matthew C.
    Solomon, Scott D.
    Tardif, Jean-Claude
    Pfeffer, Marc A.
    CIRCULATION, 2017, 136 (16) : 1560 - 1562
  • [2] Impact of canagliflozin in natriuretic peptides in patients with type 2 diabetes after hospitalization for acute heart failure
    Martin Dorado, E.
    Gonzalez Manzanares, R.
    Castillo Dominguez, J. C.
    Lopez Aguilera, J.
    Perea, J.
    Luque Moreno, A.
    Oneto Fernandez, J.
    Paredes Hurtado, N.
    Rodriguez Nieto, J.
    Gallo Fernandez, I.
    Anguita, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 902 - 902
  • [3] Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
    Tseng, Chin-Hsiao
    ONCOTARGET, 2016, 7 (38) : 62687 - 62696
  • [4] Diabetes, Heart Failure and Natriuretic Peptides
    Fritzen, K.
    Patzer, K. -H.
    Schnell, O.
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (04): : 189 - 195
  • [5] Natriuretic Peptides in Patients with Diabetes and Heart Failure - Current Recommendations
    Tonchevska, E.
    Schnell, O.
    DIABETES STOFFWECHSEL UND HERZ, 2023, 32 (01): : 25 - 30
  • [6] Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic Peptides
    Berezina, Tetiana A.
    Berezin, Oleksandr O.
    Hoppe, Uta C.
    Lichtenauer, Michael
    Berezin, Alexander E.
    DIAGNOSTICS, 2024, 14 (16)
  • [7] Heart Failure in Diabetes: Natriuretic Peptides in Focus
    Schnell, O.
    Otter, W.
    Mueller, M.
    Hummel, M.
    Mehnert, H.
    DIABETES STOFFWECHSEL UND HERZ, 2009, 18 (04): : 269 - 276
  • [8] Is it NICE to measure natriuretic peptides after a hospitalization for heart failure?
    Pagnesi, Matteo
    Adamo, Marianna
    Metra, Marco
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 785 - 787
  • [9] The influence of metformin on mortality and hospitalization in patients with heart failure and type 2 diabetes
    Retwinski, A.
    Kosmalski, M.
    Crespo-Leiro, M.
    Maggioni, A.
    Opolski, G.
    Ponikowski, P.
    Polonski, L.
    Jankowska, E.
    Drzewoski, J.
    Drozdz, J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 663 - 663
  • [10] Recent advances in natriuretic peptides in congestive heart failure
    Boerrigter, G
    Burnett, JC
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (06) : 643 - 652
12345